Author

Pedzisai A. Makoni

Rhodes University - Cited by 256 - Lipid nanocarriers - Drug delivery - Pharmaceutical analysis

Biography

Dr Pedzisai A. Makoni is an experienced pharmacist with a demonstrated history of working in academia and the pharmaceutical industry. His experience is in both sterile and oral solid dosage form manufacturing . He ia  highly skilled in the formulation, development, and assessment of lipid nanocarriers. He has a strong passion for scientific writing, research and development, and all aspects leading to the the registration of medicines.
Title
Cited by
Year
Biocompatibility of biomaterials for nanoencapsulation: Current approaches
BA Witika, PA Makoni, SK Matafwali, B Chabalenge, C Mwila, ...Nanomaterials 10 (9), 1649, 2020202
36
2020
Nano-biomimetic drug delivery vehicles: potential approaches for COVID-19 treatment
BA Witika, PA Makoni, LL Mweetwa, PV Ntemi, MTR Chikukwa, ...Molecules 25 (24), 5952, 2020202
28
2020
Enhancement of biological and pharmacological properties of an encapsulated polyphenol: Curcumin
BA Witika, PA Makoni, SK Matafwali, LL Mweetwa, GC Shandele, ...Molecules 26 (14), 44, 2021202
24
2021
Vesicular drug delivery for the treatment of topical disorders: Current and future perspectives
BA Witika, LL Mweetwa, KO Tshiamo, K Edler, SK Matafwali, PV Ntemi, ...Journal of Pharmacy and Pharmacology 73 (11), 1427-1441, 2021202
23
2021
Muco-adhesive clarithromycin-loaded nanostructured lipid carriers for ocular delivery: Formulation, characterization, cytotoxicity and stability
PA Makoni, SM Khamanga, RB WalkerJournal of Drug Delivery Science and Technology 61, 102171, 2021202
16
2021
13
2020
Application of lipid-based nanocarriers for antitubercular drug delivery: a review
AB Buya, BA Witika, AM Bapolisi, C Mwila, GK Mukubwa, PB Memvanga, ...Pharmaceutics 13 (12), 2041, 2021202
10
2021
Applications of electrospun drug-eluting nanofibers in wound healing: Current and future perspectives
N Akombaetwa, A Bwanga, PA Makoni, BA WitikaPolymers 14 (14), 2931, 2022202
6
2022
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
BA Witika, MS Poka, PH Demana, SK Matafwali, S Melamane, ...Pharmaceutics 14 (4), 83, 2022202
6
2022
Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: method scaling versus re-validation
PA Makoni, MTR Chikukwa, SMM Khamanga, RB WalkerScientia Pharmaceutica 87 (4), 31, 2019201
5
2019
Formulation, development and assment of efavirenz-loaded lipid nanocarriers
PA MakoniM. Sc (Pharmacy) in Pharmaceutics, Rhodes University, Grahamstown, South Africa, 20120
4
2014
Preformulation studies of efavirenz with lipid excipients using thermal and spectroscopic techniques
PA Makoni, KW Kasongo, RB WalkerDie Pharmazie-An International Journal of Pharmaceutical Sciences 75 (9 …, 2020202
3
2020
The use of experimental design for the development and validation of an HPLC-ECD method for the quantitation of efavirenz
PA Makoni, SM Khamanga, K Wa Kasongo, RB WalkerDie Pharmazie-An International Journal of Pharmaceutical Sciences 73 (10 …, 01801
2
2018
1
2020